Wed, Jan 03, 2024
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
More >
Thu, Dec 22, 2016
"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
